Regulation of xenogeneic porcine pancreatic islets
| Autor: | Bruce S. Schneider, Evgenij Evdokimov, Larisa Rudenko, Cheng-Hong Wei, Phillip J. Snoy, Allen K. Wensky, Jeff Jones, Judith Arcidiacono, Mark H. Lee, Keith Wonnacott |
|---|---|
| Rok vydání: | 2010 |
| Předmět: |
endocrine system
Transplantation Type 1 diabetes geography geography.geographical_feature_category endocrine system diseases business.industry Pancreatic islets Immunology medicine.disease Bioinformatics Islet Genetically modified organism Clinical trial medicine.anatomical_structure Diabetes mellitus medicine business |
| Zdroj: | Xenotransplantation. 17:329-337 |
| ISSN: | 0908-665X |
| DOI: | 10.1111/j.1399-3089.2010.00592.x |
| Popis: | The use of xenogeneic porcine pancreatic islets has been shown to be a potentially promising alternative to using human allogeneic islets to treat insulin-dependent type 1 diabetes (T1D). This article provides an overview of the existing FDA regulatory framework that would be applied to the regulation of clinical trials utilizing xenogeneic porcine pancreatic islets to treat T1D. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|